Biotinylated Human Erythropoietin R & CD131 Protein, Fc,Avitag™ (MALS verified)

ユーザーレビュー
製品番号/仕様
価格
数量
ERR-H82F3-25ug
$368.00
ERR-H82F3-200ug
$1449.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Synonyms

    Erythropoietin R & CD131

  • Source

    Biotinylated Human Erythropoietin R & CD131 Protein, Fc,Avitag (ERR-H82F3) is expressed from human 293 cells (HEK293). It contains AA Ala 25 - Pro 250 & Trp 17 - Trp 443 (Accession # P19235-1 & P32927-1).

    Predicted N-terminus: Ala 25

  • Molecular Characterization

    This protein carries a human IgG1 Fc tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 102.6 kDa. The protein migrates as 110-130 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    The protein is designed as a heterodimer.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    Erythropoietin R & CD131 SDS-PAGE

    Biotinylated Human Erythropoietin R & CD131 Protein, Fc,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    Erythropoietin R & CD131 SEC-MALS

    The purity of Biotinylated Human Erythropoietin R & CD131 Protein, Fc,Avitag (Cat. No. ERR-H82F3) is more than 90% and the molecular weight of this protein is around 205-260 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     Erythropoietin R & CD131 ELISA

    Immobilized Human EPO Protein, premium grade (Cat. No. EPO-H4214) at 10 μg/mL (100 μL/well) can bind Biotinylated Human Erythropoietin R & CD131 Protein, Fc,Avitag (Cat. No. ERR-H82F3) with a linear range of 0.002-0.156 μg/mL (QC tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

Epo (Erythropoietin) is the primary regulator of erythropoiesis and is critical for tissue oxygenation under both steady-state conditions and after acute blood loss or hypoxia. The EPO R is the primary receptor that binds to and transmits the activation signal of the EPO cytokine.ERO R is a member of the type I cytokine receptor superfamily. It usually exists as a homodimer and expressed extensively in EPO-responsive BM erythroid progenitors (BFU-E and CFU-E). The interaction of EPO with EPO R at the level of proerythroid cells activates proliferation, increases survival and promotes cell-restricted lineage erythroid differentiation. EPO also binds to the heterodimeric complex EPO-R on non-erythroid tissues (brain, heart, retina, kidney and others). This heterodimeric complex consists of one chain of EPO-R and a ubiquitous colony-stimulating factor 2 receptor β-chain (CD131). This heterodimeric receptor has been called the tissue protective receptor (TPR) of EPO. Although the interaction of EPO with TPR does not initiate erythropoiesis, it signals biochemical cascades (activation of PI3K, MARK, STAT5 and others), leading to the protection of cells from apoptosis, degeneration and cytotoxicity in general.

最新の進展

 
お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8